Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primary renal sarcoma

J E Spellman1, D L Driscoll, R P Huben

  • 1Department of Surgical Oncology, Roswell Park Cancer Institute, Buffalo, New York 14263, USA.

The American Surgeon
|May 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cryosurgical ablation of the prostate.

Urologic oncology·2011
Same author

The impact of pre-therapy extraperitoneal surgical staging on the evaluation and treatment of patients with locally advanced cervical cancer.

European journal of gynaecological oncology·2002
Same author

Pulmonary resection in metastatic uterine and cervical malignancies.

Gynecologic oncology·2001
Same author

Pericardial catheter sclerosis versus surgical procedures for pericardial effusions in cancer patients.

The Journal of cardiovascular surgery·2001
Same author

Soluble 2-substituted aminopyrido[2,3-d]pyrimidin-7-yl ureas. Structure-activity relationships against selected tyrosine kinases and exploration of in vitro and in vivo anticancer activity.

Journal of medicinal chemistry·2001
Same author

Risk factors for nodal recurrence after lymphadenectomy for melanoma.

Annals of surgical oncology·2001
Same journal

Complete Response of Merkel Cell Carcinoma to Immunotherapy and Single-Fraction Radiotherapy Following Severe COVID-19 Infection: A Case Report and Review of Immune Mechanism.

The American surgeon·2026
Same journal

Perioperative Acute Myocardial Infarction in Non-Cardiac Operations: A National Analysis.

The American surgeon·2026
Same journal

Outcomes of Completion Cholecystectomy: Association With Patient Comorbidity in a National Database.

The American surgeon·2026
Same journal

Building the Conversation: Editorial Stewardship in Contemporary Surgical Publishing.

The American surgeon·2026
Same journal

Musculoskeletal Pain in Surgeons on Operating Days.

The American surgeon·2026
Same journal

Splenectomy During Cytoreductive Surgery: Marker of Surgical Burden or Independent Predictor of Morbidity?

The American surgeon·2026
See all related articles

Primary renal sarcoma is a rare kidney cancer. Early localized disease offers a better prognosis, while invasive tumors have a poor survival rate.

Area of Science:

  • Oncology
  • Urology
  • Surgical Pathology

Background:

  • Primary renal sarcoma is a rare kidney tumor, accounting for about 1% of all kidney neoplasms.
  • Sarcomas of the kidney are aggressive malignancies with limited treatment options.

Purpose of the Study:

  • To review the treatment experience for primary renal sarcoma at Roswell Park Cancer Institute.
  • To evaluate the outcomes of patients diagnosed with primary renal sarcoma.

Main Methods:

  • Retrospective review of four patients diagnosed with primary renal sarcoma between 1976 and 1983.
  • All patients underwent radical nephrectomy for tumor removal.

Main Results:

  • Two patients had localized disease, and two had locally invasive tumors.

Related Experiment Videos

  • All patients experienced recurrence and metastatic disease.
  • Localized disease recurred at 19 and 25 months; invasive disease recurred at 4 and 5 months.
  • Mean survival for localized disease was 34 months; invasive disease survival was 6 and 10 months.

    • Conclusions:

    • Primary renal sarcoma is a rare and aggressive malignancy.
    • Localized renal sarcomas have a better prognosis than invasive ones.
    • Early detection and treatment of localized disease are critical for improved patient survival.